Paul Scorer

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer

M. Ratcliffe, Alan Sharpe, Anita Midha et al. · Clinical Cancer Research · 2017 · 303 citations

Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms

Lizz Grimwade, Lisa Happerfield, Colin Tristram et al. · British Journal of Haematology · 2009 · 76 citations · Full text

Immunology, Pathology, Cell Death +16

Prevalence of HER2 low in breast cancer subtypes using the VENTANA anti-HER2/neu (4B5) assay.

Marietta Scott, Michel E. Vandenberghe, Paul Scorer et al. · Journal of Clinical Oncology · 2021 · 49 citations

Breast Oncology, Immunology, Pathology +18

Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma

M Zając, Marietta Scott, M. Ratcliffe et al. · Diagnostic Pathology · 2019 · 47 citations · Full text

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

Paul Scorer, Marietta Scott, Nicola Lawson et al. · Diagnostic Pathology · 2018 · 36 citations · Full text